Literature DB >> 19290473

Postoperative pain management after inguinal hernia repair: lornoxicam versus tramadol.

O Mentes1, M Bagci.   

Abstract

BACKGROUND: In this randomized and prospective study, we compared the analgesic effects of lornoxicam and tramadol in patients after inguinal hernia repair.
METHODS: A total of 160 patients were assigned in a randomized manner into two groups. Group L received 8 mg lornoxicam i.v. at the end of the operation, followed by 8 mg 12 h after the operation. Group T received 1 mg/kg tramadol at the end of the operation and every 6 h up to 24 h postoperatively. The visual analog scale (VAS) score was assessed at 0, 2, 4, 8, 12, and 24 h after surgery.
RESULTS: All patients completed the study. All vital signs were within normal ranges. The mean VAS score in Group L and in Group T was 21.66 +/- 14.64 and 19.75 +/- 11.82, respectively. No significant differences were found between groups with respect to VAS score. Eight (10%) patients in Group T had nausea.
CONCLUSION: Lornoxicam 8 mg i.v. and b.i.d., tramadol 1 mg/kg at the end of the surgery and every 6 h up to 24 h after inguinal hernia repair provided rapid and effective analgesia and was well tolerated.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19290473     DOI: 10.1007/s10029-009-0486-1

Source DB:  PubMed          Journal:  Hernia        ISSN: 1248-9204            Impact factor:   4.739


  19 in total

1.  The management of pain following day-case surgery.

Authors:  G A McHugh; G M M Thoms
Journal:  Anaesthesia       Date:  2002-03       Impact factor: 6.955

2.  Intravenous tramadol versus epidural morphine for postthoracotomy pain relief: a placebo-controlled double-blind trial.

Authors:  M F James; S A Heijke; P C Gordon
Journal:  Anesth Analg       Date:  1996-07       Impact factor: 5.108

3.  Severity and impact of pain after day-surgery.

Authors:  L Beauregard; A Pomp; M Choinière
Journal:  Can J Anaesth       Date:  1998-04       Impact factor: 5.063

Review 4.  [Tolerance and safety of tramadol use. Results of international studies and data from drug surveillance].

Authors:  M Cossmann; C Kohnen; R Langford; C McCartney
Journal:  Drugs       Date:  1997       Impact factor: 9.546

5.  Efficacy and tolerability of lornoxicam versus tramadol in postoperative pain.

Authors:  H Staunstrup; J Ovesen; U T Larsen; K Elbaek; U Larsen; K Krøner
Journal:  J Clin Pharmacol       Date:  1999-08       Impact factor: 3.126

Review 6.  Tenoxicam. An update of its pharmacology and therapeutic efficacy in rheumatic diseases.

Authors:  P A Todd; S P Clissold
Journal:  Drugs       Date:  1991-04       Impact factor: 9.546

Review 7.  Efficacy of nonsteroidal anti-inflammatory drugs in the management of postoperative pain.

Authors:  C Moote
Journal:  Drugs       Date:  1992       Impact factor: 9.546

8.  Comparison of lornoxicam with tramadol in patient-controlled analgesia after gynecological surgery.

Authors:  M Karaca; H Kocoglu; A Gocmen
Journal:  Eur J Gynaecol Oncol       Date:  2006       Impact factor: 0.196

9.  Relief of postoperative pain by ibuprofen: a report of two studies.

Authors:  J D Iles
Journal:  Can J Surg       Date:  1980-05       Impact factor: 2.089

Review 10.  Postoperative pain.

Authors:  H Kehlet; J B Dahl
Journal:  World J Surg       Date:  1993 Mar-Apr       Impact factor: 3.352

View more
  2 in total

1.  Postoperative Pain Scores After Open Inguinal Hernia Repair: Comparison of Three Postoperative Analgesic Regimens.

Authors:  Francesk Mulita; Nikolaos Parchas; Konstantina Solou; Levan Tchabashvili; Foteini Gatomati; Fotios Iliopoulos; Ioannis Maroulis
Journal:  Med Arch       Date:  2020-10

2.  Novel Screen-Printed Sensor with Chemically Deposited Boron-Doped Diamond Electrode: Preparation, Characterization, and Application.

Authors:  Oleksandr Matvieiev; Renáta Šelešovská; Marian Vojs; Marián Marton; Pavol Michniak; Vojtěch Hrdlička; Michal Hatala; Lenka Janíková; Jaromíra Chýlková; Jana Skopalová; Petr Cankař; Tomáš Navrátil
Journal:  Biosensors (Basel)       Date:  2022-04-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.